Efficacy of neoadjuvant chemoradiotherapy with Metformin for locally advanced pancreatic cancer

Not Applicable

Recruiting

• Conditions: pancreatic cancer

• Registration Number: JPRN-UMIN000017694
• Lead Sponsor: Hokkaido University Graduate School of Medicine Gastroenterological Surgery 1

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2015-05-28
• Last Update Posted: 17 October 2023
• Study Completion: 2025-12-01

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 40

Inclusion Criteria

Not provided

Exclusion Criteria

1) Pulmonary fibrosis or interstitial pneumonia 2) severe infectious disease 3) Patients with uncontrolled heart failure , angina, arrhythmias, and myocardial infarction within 6 months after the onset. 4) uncontrolled diabetes 5) Patients with active infection 6) Patients with pregnant women, the possibility or intention of lactating and pregnant. 7)severe drug allergy 8)peptic ulcer and bleeding 9)obvious neurological disorder or mental disorder 10)active double cancer 11)Patients who are already administered metformin 12)other severe complications 13)The patients who are judged inadequate to the present study by Principal investigator or researcher.

Study & Design

• Study Type: Interventional
• Study Design: Not specified